BIRMINGHAM, Ala., July 16 /PRNewswire/ -- Centrix Pharmaceutical, Inc., a privately held developer and marketer of prescription and non-prescription pharmaceutical products, announced today that it has signed a Manufacturing and Supply Agreement with Cedar Pharmaceuticals for Northyx(TM) (methimazole) oral tablets. Pursuant to the Agreement, Centrix will sell and distribute four strengths, two of which (15 mg and 20 mg) have not been previously available. Northyx(TM) is manufactured and supplied by Cedar Pharmaceuticals, a privately held developer and manufacturer of pharmaceutical products.
“Northyx(TM) represents another opportunity for Centrix to provide caregivers and patients with treatment options,” said John R. (Bob) Booth, President and CEO of Centrix Pharmaceutical. “With the addition of Northyx(TM) 15 mg. and 20mg. tablets as well as the launch of Northyx(TM) 5 mg. and 10 mg. tablets, those patients suffering from hyperthyroidism can now potentially reduce the number of tablets they are required to take daily to maintain appropriate thyroid activity. The new strengths provide greater flexibility for prescribers.”
David Lohrey, President and CEO of Cedar Pharmaceuticals said, “Cedar Pharmaceuticals is looking forward to a long, successful partnership with Centrix. Centrix adds the sales, marketing resources and talent that are needed to bring the benefits of Northyx for hyperthyroidism to doctors and patients.”
About Northyx(TM)
Northyx(TM) is indicated in the medical treatment of hyperthyroidism. Long-term therapy may lead to remission of the disease. Northyx(TM) may be used to ameliorate hyperthyroidism in preparation for subtotal thyroidectomy or radioactive iodine therapy. Northyx(TM) is also used when thyroidectomy is contraindicated or not advised. Northyx(TM) is contraindicated in the presence of hypersensitivity to the drug and in nursing mothers because the drug is excreted in milk.
Please see www.northyx.com for complete Prescribing Information on Northyx(TM).
About Centrix Pharmaceutical, Inc.
Centrix Pharmaceutical is a privately-held developer and marketer of prescription and non-prescription pharmaceutical products with primary interests in Pediatrics, Gastroenterology, Women’s Health, as well as Endocrinology. Headquartered in Birmingham, Alabama, the Company’s products are marketed by its dedicated sales force in the United States.
About Cedar Pharmaceuticals
Headquartered in Shreveport, Louisiana, Cedar Pharmaceutical LLC is a virtual pharmaceutical development company, partnering with others to bring quality products to market. Cedar’s primary target products are niche prescription drugs.
Centrix Pharmaceutical, Inc.
CONTACT: Dan Feltham, Senior Group Product Manager, of CentrixPharmaceutical, Inc., +1-205-991-9870